Schoenebaum Likes United Therapeutics, Biogen Idec

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

April 2 (Bloomberg) -- Mark Schoenebaum, an analyst with ISI Group, talks about his investment strategy and stock picks for shares of biotechnology companies. He speaks with Adam Johnson and Trish Regan on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change